Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 18 (RPS2P18) is one of many processed pseudogenes of the ribosomal protein S2 (RPS2) gene in the human genome[2][7]. It is a non-coding genomic sequence that originated from a duplication and retrotransposition event of the functional RPS2 gene, which encodes a structural protein of the 40S ribosomal subunit involved in protein synthesis[7][1][3]. RPS2P18 lacks the necessary regulatory and coding elements to produce a functional protein; therefore, it does not play a direct biological role and is not associated with any established therapeutic relevance or drug interactions. Pseudogenes like RPS2P18 are generally considered non-functional relics of evolution, though some can play regulatory roles in rare cases. There is no evidence that RPS2P18 is associated with disease, drug response, or utility as a biomarker[2][7]. RPS2P18 should not be confused with the functional ribosomal protein S2 (RPS2), which is an actual protein-coding gene and part of the ribosome complex[1][3]. RPS2P18 is not a receptor, enzyme, or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 18 (RPS2P18).